BOEUF (Bonesupport Holding AB) Pretax Margin %: 20.99% (As of Mar. 2026)


BOEUF Bonesupport Holding AB BOEUF
81 GF Score
Price $21.40
GF Value $42.42
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bonesupport Holding AB Pretax Margin %?

Bonesupport Holding AB BOEUF 81 Pretax Margin % is 20.99% as of Mar. 2026. GuruFocus rates BOEUF with a GF Score™ of 81/100 and a GF Value™ of $42.42 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Bonesupport Holding AB ranks better than 86.78% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Bonesupport Holding AB's Pre-Tax Income for the three months ended in Mar. 2026 was $7.3 Mil. Bonesupport Holding AB's Revenue for the three months ended in Mar. 2026 was $34.8 Mil. Therefore, Bonesupport Holding AB's pretax margin for the quarter that ended in Mar. 2026 was 20.99%.

The historical rank and industry rank for Bonesupport Holding AB's Pretax Margin % or its related term are showing as below:

BOEUF' s Pretax Margin % Range Over the Past 10 Years
Min: -180.98   Med: -46.59   Max: 20.94
Current: 20.94


BOEUF's Pretax Margin % is ranked better than
86.78% of 817 companies
in the Medical Devices & Instruments industry
Industry Median: 2.61 vs BOEUF: 20.94

Bonesupport Holding AB  (OTCPK:BOEUF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Bonesupport Holding AB Pretax Margin % Related Terms


Bonesupport Holding AB Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Bonesupport Holding AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonesupport Holding AB Pretax Margin % Chart

Bonesupport Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -38.44 -19.68 2.66 19.21 16.99

Bonesupport Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.62 17.98 22.70 21.92 20.99

BOEUF vs ISRG, BDX, MDLN: Pretax Margin % Comparison

For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonesupport Holding AB Pretax Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Bonesupport Holding AB's Pretax Margin % falls into.


BOEUF
81GF Score
Bonesupport Holding AB BOEUF
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonesupport Holding AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Bonesupport Holding AB's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=21.469/126.396
=16.99 %

Bonesupport Holding AB's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=7.301/34.777
=20.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of 20.99% mean?
Bonesupport Holding AB (BOEUF) has a Pretax Margin % of 20.99% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Bonesupport Holding AB and its competitors. According to the industry distribution chart, Bonesupport Holding AB ranks #108 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 13.2%.
Is Bonesupport Holding AB's Pretax Margin % too high?
Bonesupport Holding AB's current Pretax Margin % is 20.99%. The Medical Devices & Instruments industry median Pretax Margin % is 2.61. Bonesupport Holding AB's value of 20.99% is 704.2% above this industry median. Based on the distribution chart, Bonesupport Holding AB ranks #108 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bonesupport Holding AB has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonesupport Holding AB ranks #108 out of 817 companies for Pretax Margin %. This places Bonesupport Holding AB in the top 13% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.61. Bonesupport Holding AB's value of 20.99% is 704.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.61, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonesupport Holding AB's current Pretax Margin % of 20.99% is 704.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Bonesupport Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonesupport Holding AB's current Pretax Margin % is 20.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (BOEUF) is currently considered Significantly Undervalued. The stock's GF Value™ is $42.42, compared to a current price of $21.40 — trading 49.6% below its estimated fair value. The current Pretax Margin % is 20.99% and 704.2% above the Medical Devices & Instruments industry median of 2.61. Bonesupport Holding AB's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Bonesupport Holding AB (BOEUF), the current Pretax Margin % is 20.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bonesupport Holding AB (BOEUF) Overvalued in 2026?

Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued. The current stock price of $21.40 is trading 49.6% below its estimated GF Value™ of $42.42. GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.

Key valuation signals for BOEUF:

  • Pretax Margin %: 20.99%
  • GF Value™: $42.42 vs. price of $21.40 (49.6% below fair value)
  • GF Score™: 81/100 with 2 warning signs
  • Industry Position: 704.2% above the Medical Devices & Instruments median (#108 of 817)

No single metric tells the full story. See the BOEUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bonesupport Holding AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
81GF Score

Get the complete analysis for BOEUF

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.40
Price
$42.42
GF Value